Form 4/A for GYRE GYRE THERAPEUTICS, INC.
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-02 · accession 0001140361-25-000827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATI | 2025-01-10 | 2025-01-03 | GYRE | Ma Songjiang | Pres, Dir | S - Sale | $11.85 | -833 | 2.92M | -0.0% | -$9,871 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | S | D | 833 | $11.85 | 2,918,467 | I By Spouse | — | — | (F1) This Form 4 amends the Form 4 filed on January 6, 2025 to reflect the correct transaction date as of January 3, 2025. The original filing incorrectly reported the transaction date as of January 3, 2024. |